Organogenesis

Yahoo Finance • 10 days ago

Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

Statistically significant (p<0.0477) DFU wound closure at 12 weeksRCT compared PuraPly®AM plus standard of care to standard of care aloneResults strengthen existing clinical evidence supporting future coverage CANTON, Mass., April 06, 20... Full story

Yahoo Finance • 10 days ago

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

CANTON, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale o... Full story

Yahoo Finance • 2 months ago

Organogenesis projects 25%-38% revenue decline in 2026 amid CMS-driven market disruption

Earnings Call Insights: Organogenesis Holdings Inc. (ORGO) Q4 2025 MANAGEMENT VIEW * CEO Gary Gillheeney highlighted record sales in the fourth quarter, stating the company "delivered record sales results, which exceeded the high end o... Full story

Yahoo Finance • 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle Pey... Full story

Yahoo Finance • 4 months ago

Organogenesis drops as Medicare to pull skin substitute LCDs (update)

[CMS] gustavofrazao Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) and MiMedx (MDXG [https://seekingalpha.com/symbol/MDXG]) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdra... Full story

Yahoo Finance • 4 months ago

Biggest stock movers Tuesday: RILY, ORGO, KYTX, RC, LWLG and more

[Stock Market] sweetym/iStock via Getty Images U.S. stock futures retreated Tuesday as investors adopted a cautious stance ahead of November’s employment data, a key indicator for the labor market’s health. Here are some of Tuesday's big... Full story

Yahoo Finance • 4 months ago

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain

Clinical Development Program Appropriate for Rolling BLA Submission Expected by the End of 2025 CANTON, Mass., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focuse... Full story

Yahoo Finance • 4 months ago

December 2025's Top Penny Stocks With Promising Potential

As the United States market experiences fluctuations, with technology shares weighing on major indices like the Nasdaq, investors are closely monitoring economic indicators and Federal Reserve actions. In this context, penny stocks—often s... Full story

Yahoo Finance • 6 months ago

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025

CANTON, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 7 months ago

Organogenesis hits setback as second late-stage ReNu study misses key endpoint

[A senior Asian woman massaging her knee, suffering from pain in leg while sitting on sofa in the living room at home] Thai Liang Lim/iStock via Getty Images * Organogenesis (NASDAQ:ORGO [https://seekingalpha.com/symbol/ORGO]) said a se... Full story

Yahoo Finance • 7 months ago

Organogenesis Provides Update on Second Phase 3 ReNu® Study

Company maintains confidence in ReNu as innovative pain management therapy Second Phase 3 trial demonstrates numerical improvement in baseline pain reduction over the first Phase 3 trial despite not meeting the primary endpoint Statistica... Full story

Yahoo Finance • 8 months ago

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 9 months ago

Biggest stock movers Tuesday: NVDA, TTD, and more

[Man looking at currency trading app on his smart phone from his home office] Alistair Berg Stock futures edged higher early Tuesday as investors awaited the kickoff of earnings season, with major banks JPMorgan (JPM), Citigroup (C), and... Full story

Yahoo Finance • 9 months ago

CMS proposed payment rule aims to cut waste, boost chronic disease management

[Centers For Medicare And Medicaid Services Headquarters] A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as launch a new payment model centered on chronic disease man... Full story

Yahoo Finance • 10 months ago

Monday 6/9 Insider Buying Report: AMPY, ORGO

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is th... Full story

Yahoo Finance • last year

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • last year

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wo... Full story

Yahoo Finance • last year

Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025

CANTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story

Yahoo Finance • 2 years ago

Organogenesis (ORGO) Q3 2023 Earnings Call Transcript

Welcome, ladies and gentlemen, to the third quarter 2023 earnings conference call for Organogenesis Holdings Inc. At this time, all participants have been placed in a listen-only mode. Before we begin, I would like to remind everyone that... Full story

Yahoo Finance • 2 years ago

Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results

CANTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wou... Full story